However, the roles of HIC1 are inconsistent and controversial among several cancers, there are no pan-cancer analysis of HIC1 and the associations of HIC1 with tumor immune microenvironment and the immunotherapeutic efficacy are still largely unknown. This evidence concerns the gene HIC1 and neoplasm.